Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Weekly News Recap #Phispers
1. 3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate
2. Lcz 696
3. Lcz-696
4. Lcz696
5. Sacubitril And Valsartan Drug Combination
6. Sacubitril And Valsartan Sodium Anhydrous Drug Combination
7. Sacubitril And Valsartan Sodium Hydrate Drug Combination
8. Sacubitril Valsartan Drug Combination
9. Sacubitril Valsartan Sodium Anhydrous
10. Sacubitril Valsartan Sodium Hydrate
11. Sacubitril-valsartan
12. Sacubitril-valsartan Sodium Anhydrous Drug Combination
13. Sacubitril-valsartan Sodium Hydrate Drug Combination
14. Trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) Hemipentahydrate
1. Sacubitril Valsartan Sodium Hydrate
2. Sacubitril Mixture With Valsartan
3. Wb8ft61183
4. Lcz 696
5. Sacubitril Valsartan Sodium Hydrate (jan)
6. Sacubitril Valsartan Sodium Hydrate [jan]
7. Entresto (tn)
8. Unii-wb8ft61183
9. Valsartan Mixture With Ahu-377
10. Ex-a2849
11. Mfcd29477717
12. 3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate
13. Ac-29037
14. Sucabitril Valsartan Sodium Hydrate
15. Trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) Hemipentahydrate
16. D10226
17. Valsartan Ahu-377 Sodium Hemipentahydrate
18. Q27292546
19. L-valine, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Compd. With .alpha.-ethyl (.alpha.r,.gamma.s)-.gamma.-((3-carboxy-1-oxopropyl)amino)-.alpha.-methyl(1,1'-biphenyl)-4-pentanoate, Sodium Salt, Hydrate (2:2:6:5)
20. L-valine, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Compd. With Alpha-ethyl(alphar,gammas)-gamma-((3-carboxy-1-oxopropyl)amino)-alpha-methyl(1,1'-biphenyl)-4-pentanoate, Sodium Salt, Hydrate (2:2:6:5)
Molecular Weight | 1916.0 g/mol |
---|---|
Molecular Formula | C96H120N12Na6O21 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 29 |
Rotatable Bond Count | 40 |
Exact Mass | 1915.8110694 g/mol |
Monoisotopic Mass | 1914.8077146 g/mol |
Topological Polar Surface Area | 396 Ų |
Heavy Atom Count | 135 |
Formal Charge | 0 |
Complexity | 1140 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 15 |
Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
Angiotensin Receptor Antagonists
Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR. (See all compounds classified as Angiotensin Receptor Antagonists.)
C09DX04
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-12-22
Pay. Date : 2017-11-08
DMF Number : 31574
Submission : 2017-08-29
Status : Active
Type : II
Date of Issue : 2022-07-28
Valid Till : 2025-11-30
Written Confirmation Number : WC-0390
Address of the Firm :
Registrant Name : Pami Future Co., Ltd.
Registration Date : 2024-07-15
Registration Number : No. 583-30-ND(A)
Manufacturer Name : Dr. Reddy\'s Laboratories Limited@Dr. Reddy\'s Laboratories Limited
Manufacturer Address : CTO-SEZ Process Unit-01, Sector No.\'s 28 to 34, 36 to 37, 40, 50 to 53 & 03, Survey No.\'s 57 to 58, 60, 72 to 73, 76 to 77 & 80, Devunipalavalasa Village, Ranasthalam Mandal, Srikakulam District 532409, Andhra Pradesh, India@CTO Unit-VI, APIIC Industrial Estate, Pydibhimavaram Village, Ranasthalam Mandal, Srikakulam District, Andhra Pradesh - 532 409, India
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-09-04
Pay. Date : 2017-12-20
DMF Number : 32337
Submission : 2017-12-21
Status : Active
Type : II
Available Reg Filing : ASMF |
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37994
Submission : 2023-03-09
Status : Active
Type : II
Date of Issue : 2022-08-11
Valid Till : 2025-06-26
Written Confirmation Number : WC-0054
Address of the Firm :
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-11-09
Pay. Date : 2021-09-20
DMF Number : 35868
Submission : 2021-04-28
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-06-20
Pay. Date : 2019-05-07
DMF Number : 33657
Submission : 2019-05-09
Status : Active
Type : II
Date of Issue : 2019-05-06
Valid Till : 2022-05-05
Written Confirmation Number : WC-362
Address of the Firm :
NDC Package Code : 69037-0039
Start Marketing Date : 2015-07-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2017-12-22
Pay. Date : 2017-11-08
DMF Number : 31574
Submission : 2017-08-29
Status : Active
Type : II
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
GDUFA
DMF Review : Complete
Rev. Date : 2018-09-04
Pay. Date : 2017-12-20
DMF Number : 32337
Submission : 2017-12-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37994
Submission : 2023-03-09
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-04-12
Pay. Date : 2018-12-20
DMF Number : 33457
Submission : 2019-02-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-03-27
Pay. Date : 2019-02-05
DMF Number : 33452
Submission : 2019-02-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33344
Submission : 2019-03-15
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-03-08
Pay. Date : 2019-02-01
DMF Number : 33455
Submission : 2019-01-10
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32171
Submission : 2017-12-16
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-04-30
Pay. Date : 2019-04-15
DMF Number : 33398
Submission : 2018-12-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-02-19
Pay. Date : 2018-10-31
DMF Number : 32325
Submission : 2017-12-30
Status : Active
Type : II
SACUBITRIL VALSARTAN SODIUM HYDRATE
NDC Package Code : 59651-335
Start Marketing Date : 2024-01-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (43kg/50kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
SACUBITRIL VALSARTAN SODIUM HYDRATE
NDC Package Code : 66064-1026
Start Marketing Date : 2017-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
SACUBITRIL VALSARTAN SODIUM HYDRATE
NDC Package Code : 69037-0040
Start Marketing Date : 2015-07-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
SACUBITRIL VALSARTAN SODIUM HYDRATE
NDC Package Code : 69037-0039
Start Marketing Date : 2015-07-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
SACUBITRIL VALSARTAN SODIUM HYDRATE
NDC Package Code : 69037-0043
Start Marketing Date : 2015-07-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
SACUBITRIL VALSARTAN SODIUM ANHYDROUS
NDC Package Code : 69766-045
Start Marketing Date : 2017-12-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
SACUBITRIL VALSARTAN SODIUM HYDRATE
NDC Package Code : 69766-042
Start Marketing Date : 2017-12-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
SACUBITRIL VALSARTAN SODIUM HYDRATE
NDC Package Code : 69766-062
Start Marketing Date : 2018-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
SACUBITRIL VALSARTAN SODIUM HYDRATE
NDC Package Code : 64220-222
Start Marketing Date : 2024-07-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
SACUBITRIL VALSARTAN SODIUM HYDRATE
NDC Package Code : 65344-0034
Start Marketing Date : 2021-03-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
About the Company : Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the c...
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs)...
About the Company : Virupaksha Organics, founded in 2003 by G. Chandra Mouliswar Reddy, is committed to delivering products of the utmost quality to its customers. In a span of less than 20 years, the...
About the Company : Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory thera...
About the Company : Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to G...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
About the Company : Octavius Pharma is a global leader in Directly Compressible Granules with over 40 years of experience in Formulation development, manufacturing and commercialization. It offers a w...
About the Company : Amara Labs Pvt Ltd is a WHO-GMP certified manufacturing company wholly owned by a team of technocrats with working experience of more than 20 years in Multi-Nationals Companies lik...
About the Company : Divi's Laboratories Limited is a leading independent contract manufacturer of Active Pharmaceutical Ingredients and registered intermediates. We custom / exclusively manufacture fo...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
(R) -tert-butyl-((1,1’-biphenyl)-4-yl-3-hydropan...
CAS Number : 1426129-50-1
End Use API : Sacubitril-Valsartan
About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...
(S) -5-((biphenyl-4-yl)methyl)pyrroidine-2-ketone
CAS Number : 1038924-61-6
End Use API : Sacubitril-Valsartan
About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...
(S)-5-(biphenyl-4-(tert butoxyl carbonyl)amino-2-m...
CAS Number : 1012341-50-2
End Use API : Sacubitril-Valsartan
About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...
(2R,4S)-4-amino-5-(biphenyl-4-yl)-2-methylpentanoi...
CAS Number : 149690-12-0
End Use API : Sacubitril-Valsartan
About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...
(2e,4r)-5-(1, 1 '-biphenyl)-4-yl-4-(((1, 1 -dimeth...
CAS Number : 1012341-48-8
End Use API : Sacubitril-Valsartan
About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...
Sacubitril Hemicalcium
CAS Number : 1369773-39-6
End Use API : Sacubitril-Valsartan
About The Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and ch...
(R)-tert-butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxy...
CAS Number : 1426129-50-1
End Use API : Sacubitril-Valsartan
About The Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and ch...
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxyca...
CAS Number : 1012341-50-2
End Use API : Sacubitril-Valsartan
About The Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and ch...
CAS Number : 149690-12-0
End Use API : Sacubitril-Valsartan
About The Company : Shanghai Stepuppharm has a strong technical development troop and most of our technological backbone are Senior R&D persons and have more than 10 years experien...
Regulatory Info :
Registration Country : Switzerland
Brand Name : Entresto
Dosage Form : Film-Coated Tablets
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Entresto
Dosage Form : Film-Coated Tablets
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Entresto
Dosage Form : Film-Coated Tablets
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Entresto
Dosage Form : Film-Coated Tablets
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Entresto
Dosage Form : Filmtabl
Dosage Strength : 50mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Entresto
Dosage Form : Film-Coated Tablets
Dosage Strength : 50mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
Global Sales Information
Market Place
Reply
16 Sep 2024
Reply
24 Jun 2023
Reply
22 May 2023
Reply
01 Oct 2022
Reply
09 Sep 2022
Reply
05 Sep 2022
Reply
26 Jul 2022
Reply
30 Jun 2022
Reply
23 Nov 2021
Reply
15 Sep 2021
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?